Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Striking the target in iron overload disorders.

Finberg KE.

J Clin Invest. 2013 Apr;123(4):1424-7. doi: 10.1172/JCI68889. Epub 2013 Mar 25.

2.

Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.

Guo S, Casu C, Gardenghi S, Booten S, Aghajan M, Peralta R, Watt A, Freier S, Monia BP, Rivella S.

J Clin Invest. 2013 Apr;123(4):1531-41. doi: 10.1172/JCI66969. Epub 2013 Mar 25.

3.

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Schmidt PJ, Toudjarska I, Sendamarai AK, Racie T, Milstein S, Bettencourt BR, Hettinger J, Bumcrot D, Fleming MD.

Blood. 2013 Feb 14;121(7):1200-8. doi: 10.1182/blood-2012-09-453977. Epub 2012 Dec 6.

4.

Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice.

Finberg KE, Whittlesey RL, Andrews NC.

Blood. 2011 Apr 28;117(17):4590-9. doi: 10.1182/blood-2010-10-315507. Epub 2011 Feb 25.

5.

Iron and hepcidin: a story of recycling and balance.

Camaschella C.

Hematology Am Soc Hematol Educ Program. 2013;2013:1-8. doi: 10.1182/asheducation-2013.1.1.

PMID:
24319154
6.

Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.

Nai A, Pagani A, Mandelli G, Lidonnici MR, Silvestri L, Ferrari G, Camaschella C.

Blood. 2012 May 24;119(21):5021-9. doi: 10.1182/blood-2012-01-401885. Epub 2012 Apr 6.

7.

Treating iron overload.

Camaschella C.

N Engl J Med. 2013 Jun 13;368(24):2325-7. doi: 10.1056/NEJMcibr1304338. No abstract available.

PMID:
23758239
8.

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.

Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S.

PLoS One. 2012;7(11):e48804. doi: 10.1371/journal.pone.0048804. Epub 2012 Nov 5.

9.

Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.

Haematologica. 2007 May;92(5):583-8.

10.

Hepcidin biology and therapeutic applications.

Nemeth E.

Expert Rev Hematol. 2010 Apr;3(2):153-5. doi: 10.1586/ehm.10.1.

PMID:
21083458
11.

The influence of hemochromatosis mutations on iron overload of thalassemia major.

Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C.

Haematologica. 1999 Sep;84(9):799-803.

12.

Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred.

Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Sánchez-Anzaldo J, Ruiz-Delgado GJ, Jiménez-González C, Carrera B.

Rev Invest Clin. 2001 Mar-Apr;53(2):117-20.

PMID:
11421105
13.

Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis.

Gnana-Prakasam JP, Baldowski RB, Ananth S, Martin PM, Smith SB, Ganapathy V.

Mol Vis. 2014 Apr 26;20:561-74. eCollection 2014.

14.

Iron disorders of genetic origin: a changing world.

Brissot P, Bardou-Jacquet E, Jouanolle AM, Loréal O.

Trends Mol Med. 2011 Dec;17(12):707-13. doi: 10.1016/j.molmed.2011.07.004. Epub 2011 Aug 20. Review.

PMID:
21862411
15.

Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.

Finberg KE, Whittlesey RL, Fleming MD, Andrews NC.

Blood. 2010 May 6;115(18):3817-26. doi: 10.1182/blood-2009-05-224808. Epub 2010 Mar 3.

16.

Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).

Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K, Andrews NC, Fleming MD.

Nat Genet. 2008 May;40(5):569-71. doi: 10.1038/ng.130. Epub 2008 Apr 13.

17.

A strong anti-inflammatory signature revealed by liver transcription profiling of Tmprss6-/- mice.

Riba M, Rausa M, Sorosina M, Cittaro D, Garcia Manteiga JM, Nai A, Pagani A, Martinelli-Boneschi F, Stupka E, Camaschella C, Silvestri L.

PLoS One. 2013 Jul 29;8(7):e69694. doi: 10.1371/journal.pone.0069694. Print 2013.

18.

[Hereditary hemochromatosis].

Dantas W.

Rev Gastroenterol Peru. 2001 Jan-Mar;21(1):42-55. Review. Portuguese.

PMID:
12170286
19.

Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.

Lakhal S, Schödel J, Townsend AR, Pugh CW, Ratcliffe PJ, Mole DR.

J Biol Chem. 2011 Feb 11;286(6):4090-7. doi: 10.1074/jbc.M110.173096. Epub 2010 Oct 21.

20.

Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.

Sham RL, Ou CY, Cappuccio J, Braggins C, Dunnigan K, Phatak PD.

Blood Cells Mol Dis. 1997 Aug;23(2):314-20.

PMID:
9410475
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk